North Korea says COVID-19 vaccines are 'no panacea,' warns of lengthy battle

  • 📰 YahooSG
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 71%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

North Korea was expected to receive nearly two million doses of AstraZeneca's COVID-19 vaccine by the first half of this year, via the COVAX sharing programme.

Streamen Sie Netflix or Pay TV channels such as SKY, DAZN, Maxdome, beliebigen Filme oder Fernsehsendungen auf Ihren Großbildschirm.Germany is cancelling its iconic Oktoberfest beer festival for the second year running due to the coronavirus pandemic, Bavaria's state premier Markus Soeder said Monday.

” Following a four-year rejection of multilateralism under the presidency of Donald Trump, the Biden administration has pledged to re-engage with UN institutions, rejoining the World Health Organization and Paris climate agreement, and launching a bid to return to the UN Human Rights Council.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

South Korea says AstraZeneca, Pfizer COVID-19 vaccines 87% effective after first shotOne dose of COVID-19 vaccines from AstraZeneca Plc and Pfizer was 86.6% effective in preventing infections among people aged 60 and older, real world data released by South Korea showed on Wednesday. Data by the Korea Disease Control and Prevention Agency (KDCA) showed the Pfizer vaccine, jointly developed by BioNTech, was 89.7% effective in preventing infection at least two weeks after a first dose was given, while the AstraZeneca shot was 86.0% effective. Its analysis is based on more than 3.5 million people in South Korea aged 60 and older for two months from Feb. 26 and included 521,133 people who received a first dose of either Pfizer or AstraZeneca shot.
Source: YahooSG - 🏆 3. / 71 Read more »